UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 431

Sortiert nach

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases

British journal of cancer, 2007-10, Vol.97 (8), p.1035-1039

2007

Volltextzugriff (PDF)

ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas

Journal of Cancer, 2015, Vol.6 (1), p.70-81

2015

Volltextzugriff (PDF)

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line

Cell proliferation, 2011-04, Vol.44 (2), p.139-146

2011

Volltextzugriff (PDF)

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

ESMO open, 2022-12, Vol.7 (6), p.100634, Article 100634

2022

Volltextzugriff (PDF)

AMAROS Study: Overall Survival in Breast Cancer Subtypes

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-08, Vol.27 (8), p.485-486

2015

Volltextzugriff (PDF)

Neurolysis versus anterior transposition of the ulnar nerve in cubital tunnel syndrome: a 12 years single secondary specialist centre experience

Musculoskeletal surgery, 2021-04, Vol.105 (1), p.69-74

2021

Volltextzugriff (PDF)

1629 Emergencies in cancer patients: Data on 15,623 cases from a large volume single centre

European journal of cancer (1990), 2015-09, Vol.51, p.S248-S248

2015

Volltextzugriff (PDF)

1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study

European journal of cancer (1990), 2015-09, Vol.51, p.S315-S315

2015

Volltextzugriff (PDF)

Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis

Clinical & translational oncology, 2016, Vol.18 (1), p.40-46

2016

Volltextzugriff (PDF)

Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer

Current medical research and opinion, 2010-03, Vol.26 (3), p.707-711

2010

Volltextzugriff (PDF)

3 CORRELATION BETWEEN IGF1R AND CMET EXPRESSION AND OUTCOME OF PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH CETUXIMAB PLUS CHEMOTHERAPY

Cancer treatment reviews, 2010, Vol.36, p.S95-S96

2010

Volltextzugriff (PDF)

696P Is it possible to improve the prognostic ability of the IMDC score? Validation of the Meet-URO score in metastatic renal cell carcinoma (mRCC) patients (pts) receiving first-line nivolumab plus ipilimumab in the Italian Expanded Access Program (EAP)

Annals of oncology, 2021-09, Vol.32, p.S709-S709

2021

Volltextzugriff (PDF)

Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

European journal of cancer (1990), 1996-05, Vol.32 (5), p.802-806

1996

Volltextzugriff (PDF)

5092 Molecular predictive factors of response to taxanes and anthracyclines in breast cancer: toward a targeted perspective for cytotoxic therapy

European journal of cancer supplements, 2009, Vol.7 (2), p.288-288

2009

Volltextzugriff (PDF)

ERCC1 as biomarker of response to oxaliplatin in colorectal cancer: To induce or not induce … this is the problem. preliminary data from liquid biopsy

Annals of oncology, 2015-10, Vol.26, p.vi39

2015

Volltextzugriff (PDF)

Emergencies in cancer patients: data on 15,623 cases from a large volume single centre from 2001 to 2013

Annals of oncology, 2015-10, Vol.26, p.vi134

2015

Volltextzugriff (PDF)

Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: a restrospective multicenter observational study

Annals of oncology, 2015-10, Vol.26, p.vi6

2015

Volltextzugriff (PDF)

The Immune Response to Tumors as a Tool toward Immunotherapy

Clinical & developmental immunology, 2011-01, Vol.2011, p.894704-12

2011

Volltextzugriff (PDF)

Kras Mutational Status and Oxaliplatin Sensitivity: The Other Side of the Moon?

Annals of oncology, 2012-09, Vol.23, p.ix84-ix85

2012

Volltextzugriff (PDF)

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11509-e11509

2011

Volltextzugriff (PDF)

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line: Anti-tumour and anti-angiogenetic effects of zoledronic acid

Cell proliferation, 2011-04, Vol.44 (2), p.139-146

2011

Volltextzugriff (PDF)

KRAS and BRAF mutational status and PTEN, cMET, and IGF1R expression as predictive markers of response to cetuximab plus chemotherapy in metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14065-e14065

2010

Volltextzugriff (PDF)

Polymorphisms in VEGF, eNOS, COX-2, and IL-8 as predictive markers of response to bevacizumab

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13502-e13502

2010

Volltextzugriff (PDF)

Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU/FA) for unresectable liver metastases

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3576-3576

2006

Volltextzugriff (PDF)

Toxic epidermal necrolysis during chlorambucil therapy in chronic lymphocytic leukaemia

European journal of cancer & clinical oncology, 1990, Vol.26 (11), p.1262-1262

1990

Volltextzugriff (PDF)

1 – 25 von 431

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(388)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases

ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

AMAROS Study: Overall Survival in Breast Cancer Subtypes

Neurolysis versus anterior transposition of the ulnar nerve in cubital tunnel syndrome: a 12 years single secondary specialist centre experience

1629 Emergencies in cancer patients: Data on 15,623 cases from a large volume single centre

1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study

Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis

Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer

3 CORRELATION BETWEEN IGF1R AND CMET EXPRESSION AND OUTCOME OF PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH CETUXIMAB PLUS CHEMOTHERAPY

696P Is it possible to improve the prognostic ability of the IMDC score? Validation of the Meet-URO score in metastatic renal cell carcinoma (mRCC) patients (pts) receiving first-line nivolumab plus ipilimumab in the Italian Expanded Access Program (EAP)

Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

5092 Molecular predictive factors of response to taxanes and anthracyclines in breast cancer: toward a targeted perspective for cytotoxic therapy

ERCC1 as biomarker of response to oxaliplatin in colorectal cancer: To induce or not induce … this is the problem. preliminary data from liquid biopsy

Emergencies in cancer patients: data on 15,623 cases from a large volume single centre from 2001 to 2013

Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: a restrospective multicenter observational study

The Immune Response to Tumors as a Tool toward Immunotherapy

Kras Mutational Status and Oxaliplatin Sensitivity: The Other Side of the Moon?

Treatment of HER2-negative metastatic breast cancer (MBC) with bevacizumab (BEV) plus paclitaxel (TXL): A single-center phase II study

Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line: Anti-tumour and anti-angiogenetic effects of zoledronic acid

KRAS and BRAF mutational status and PTEN, cMET, and IGF1R expression as predictive markers of response to cetuximab plus chemotherapy in metastatic colorectal cancer (mCRC)

Polymorphisms in VEGF, eNOS, COX-2, and IL-8 as predictive markers of response to bevacizumab

Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU/FA) for unresectable liver metastases

Toxic epidermal necrolysis during chlorambucil therapy in chronic lymphocytic leukaemia

Aktive Filter

Suchergebnisse filtern